Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
about
Ferroptosis, a new form of cell death, and its relationships with tumourous diseasesLeptomeningeal Carcinomatosis in Gastric Cancer: A Therapeutical ChallengeThe Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.MUC1-C activates BMI1 in human cancer cells.DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cellsMUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.Induced pluripotent stem cells as a cellular model for studying Down Syndrome.BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions.MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.MUC1-C activates EZH2 expression and function in human cancer cells.Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.MUC1-C is a target in lenalidomide resistant multiple myeloma.CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway.MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma.The Role of Ferroptosis in Cancer Development and Treatment Response.Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.
P2860
Q28076336-93D86242-66C2-4644-9097-C9577E012BBAQ33565733-A6372585-A98B-46B0-A504-94F8170A7B6FQ33659621-863CA7B6-511F-4568-A69C-A6F3F77F94FFQ33704573-7D069C21-7A00-482C-AD80-CFA7D25CE4F5Q37433340-42222277-E640-47EC-8FBB-194A05845ED7Q37457356-A323DD2F-6DCB-4652-90DE-C9EFB4DA35E6Q37581014-A1A350D6-D8C0-4078-A69D-0275F2C29BABQ37705790-EF4ECAAD-19AE-4715-9DDC-4772734D1DDDQ38744303-10E5436F-44C1-465F-8932-3DF5DF945BCDQ41286875-54BE4F03-E5E1-4B91-9E99-797A6A9C1494Q42378328-8458B227-B7BF-45C4-A511-9D1491C2780AQ46345708-7DB16D91-823F-4C22-9665-6FB2CC0976EDQ47642087-C302D8BF-B65D-4B4E-94A8-DF6C0D775286Q48146766-9E28D3DB-FE1A-4356-B136-4DE6A34A4967Q48548938-78E986FE-34F1-43F9-A863-6E0A71B8E8B4Q49178791-48F477D9-42F7-41B3-8B03-7366CEFDD2BDQ54957053-ED818C1E-7072-4B30-82B7-8F7AB13F9FD6Q55264209-54BE4F5F-9D9F-4961-B471-889CBF8852F4
P2860
Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional interactions of the ...... -negative breast cancer cells.
@en
Functional interactions of the ...... -negative breast cancer cells.
@nl
type
label
Functional interactions of the ...... -negative breast cancer cells.
@en
Functional interactions of the ...... -negative breast cancer cells.
@nl
prefLabel
Functional interactions of the ...... -negative breast cancer cells.
@en
Functional interactions of the ...... -negative breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Functional interactions of the ...... -negative breast cancer cells.
@en
P2093
Ashujit Tagde
Donald Kufe
Hasan Rajabi
Hidekazu Takahashi
Maroof Alam
Masanori Hasegawa
Masayuki Hiraki
Takahiro Maeda
Vikas P Sukhatme
P2860
P304
11756-11769
P356
10.18632/ONCOTARGET.7598
P407
P577
2016-02-22T00:00:00Z